Merck & Co. Statistics

Total Valuation

Merck & Co. has a market cap or net worth of BRL 1.17 trillion. The enterprise value is 1.31 trillion.

Market Cap	1.17T
Enterprise Value	1.31T

Important Dates

The next estimated earnings date is Tuesday, July 29, 2025.

Earnings Date	Jul 29, 2025
Ex-Dividend Date	Jun 13, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.30%
Shares Change (QoQ)	-0.24%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	2.51B

Valuation Ratios

The trailing PE ratio is 11.72 and the forward PE ratio is 9.38.

PE Ratio	11.72
Forward PE	9.38
PS Ratio	3.20
PB Ratio	4.22
P/TBV Ratio	18.76
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.12, with an EV/FCF ratio of 13.45.

EV / Earnings	13.15
EV / Sales	3.70
EV / EBITDA	8.12
EV / EBIT	9.69
EV / FCF	13.45

Financial Position

The company has a current ratio of 1.41, with a Debt / Equity ratio of 0.72.

Current Ratio	1.41
Quick Ratio	0.83
Debt / Equity	0.72
Debt / EBITDA	1.20
Debt / FCF	2.04
Interest Coverage	19.06

Financial Efficiency

Return on equity (ROE) is 39.29% and return on invested capital (ROIC) is 19.33%.

Return on Equity (ROE)	39.29%
Return on Assets (ROA)	13.81%
Return on Invested Capital (ROIC)	19.33%
Return on Capital Employed (ROCE)	27.14%
Revenue Per Employee	4.95M
Profits Per Employee	1.35M
Employee Count	75,000
Asset Turnover	0.58
Inventory Turnover	2.31

Taxes

In the past 12 months, Merck & Co. has paid 15.58 billion in taxes.

Income Tax	15.58B
Effective Tax Rate	13.48%

Stock Price Statistics

The stock price has decreased by -31.99% in the last 52 weeks. The beta is 0.40, so Merck & Co.'s price volatility has been lower than the market average.

Beta (5Y)	0.40
52-Week Price Change	-31.99%
50-Day Moving Average	55.25
200-Day Moving Average	66.71
Relative Strength Index (RSI)	62.83
Average Volume (20 Days)	6,792

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.16

Income Statement

In the last 12 months, Merck & Co. had revenue of BRL 366.50 billion and earned 99.96 billion in profits. Earnings per share was 39.44.

Revenue	366.50B
Gross Profit	282.46B
Operating Income	139.96B
Pretax Income	115.64B
Net Income	99.96B
EBITDA	165.10B
EBIT	139.96B
Earnings Per Share (EPS)	39.44

Full Income Statement

Balance Sheet

The company has 52.91 billion in cash and 199.78 billion in debt, giving a net cash position of -146.87 billion.

Cash & Cash Equivalents	52.91B
Total Debt	199.78B
Net Cash	-146.87B
Net Cash Per Share	n/a
Equity (Book Value)	277.50B
Book Value Per Share	110.14
Working Capital	59.22B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 119.70 billion and capital expenditures -22.01 billion, giving a free cash flow of 97.69 billion.

Operating Cash Flow	119.70B
Capital Expenditures	-22.01B
Free Cash Flow	97.69B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 77.07%, with operating and profit margins of 38.19% and 27.27%.

Gross Margin	77.07%
Operating Margin	38.19%
Pretax Margin	31.55%
Profit Margin	27.27%
EBITDA Margin	45.05%
EBIT Margin	38.19%
FCF Margin	26.66%

Dividends & Yields

This stock pays an annual dividend of 1.56, which amounts to a dividend yield of 2.65%.

Dividend Per Share	1.56
Dividend Yield	2.65%
Dividend Growth (YoY)	18.42%
Years of Dividend Growth	2
Payout Ratio	45.54%
Buyback Yield	0.30%
Shareholder Yield	2.94%
Earnings Yield	8.53%
FCF Yield	8.34%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on October 29, 2020. It was a forward split with a ratio of 8.

Last Split Date	Oct 29, 2020
Split Type	Forward
Split Ratio	8

Scores

Merck & Co. has an Altman Z-Score of 4.7 and a Piotroski F-Score of 7.

Altman Z-Score	4.7
Piotroski F-Score	7